Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility*
暂无分享,去创建一个
K. Handa | D. Withers | S. Hakomori | W. Steelant | M. Ono | Y. Kawakami | R. Baek | K. Kawakami
[1] M. Hemler,et al. Specific tetraspanin functions , 2001, The Journal of cell biology.
[2] F. Berditchevski. Complexes of tetraspanins with integrins: more than meets the eye. , 2001, Journal of cell science.
[3] K. Handa,et al. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. , 2001, International journal of oncology.
[4] K. Handa,et al. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. , 2001, Biochemistry.
[5] S. Hanash,et al. The Major CD9 and CD81 Molecular Partner , 2001, The Journal of Biological Chemistry.
[6] K. Handa,et al. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. , 2000, Biochemical and biophysical research communications.
[7] K. Handa,et al. Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM. , 2000, Biochemical and biophysical research communications.
[8] D. Azorsa,et al. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. , 1999, The Biochemical journal.
[9] K. Handa,et al. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. , 1999, Cancer research.
[10] K. Iwabuchi,et al. Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling* , 1998, The Journal of Biological Chemistry.
[11] C. Boucheix,et al. CD19 Is Linked to the Integrin-associated Tetraspans CD9, CD81, and CD82* , 1998, The Journal of Biological Chemistry.
[12] M. Hemler. Integrin associated proteins. , 1998, Current opinion in cell biology.
[13] K. Iwabuchi,et al. GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.
[14] K. Handa,et al. A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. , 1997, Biochemical and biophysical research communications.
[15] B. Sordat,et al. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.
[16] C. Peschle,et al. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. , 1997, Journal of lipid research.
[17] S. Levy,et al. The tetraspanin superfamily: molecular facilitators , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] S. Yamagata,et al. Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells. , 1997, Biochemical and biophysical research communications.
[19] W. Rodgers,et al. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains , 1996, The Journal of cell biology.
[20] Y. Miyagi,et al. Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. , 1996, Journal of biochemistry.
[21] F. Berditchevski,et al. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). , 1996, Journal of immunology.
[22] W. Carter,et al. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein , 1996, The Journal of cell biology.
[23] M. Adachi,et al. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. , 1995, Cancer research.
[24] D. Brown,et al. Triton X-100-resistant membrane complexes from cultured kidney epithelial cells contain the Src family protein tyrosine kinase p62yes. , 1994, The Journal of biological chemistry.
[25] S. Hakomori,et al. Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.
[26] Y. Kikkawa,et al. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Weitzman,et al. The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. , 1993, The Journal of biological chemistry.
[28] T. Sasaki,et al. Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. , 1993, The Journal of biological chemistry.
[29] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[30] M. Seno,et al. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility , 1991, The Journal of experimental medicine.
[31] W. Carter,et al. Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes , 1991, Cell.
[32] S. Hakomori,et al. A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. , 1991, Biochemistry.
[33] M. Hendrix,et al. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. , 1989, Cancer research.
[34] S. Hakomori,et al. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. , 1988, Cancer research.
[35] K. Yamada,et al. Biosynthesis and acquisition of biological activity of the fibronectin receptor. , 1987, The Journal of biological chemistry.
[36] C. Ewing,et al. The erasable Western blot. , 1987, Analytical biochemistry.
[37] W. Stoffel,et al. Individual exons encode the integral membrane domains of human myelin proteolipid protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Kingsley,et al. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.
[39] M. Tagawa,et al. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma. , 1985, The Journal of biological chemistry.
[40] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[41] W. Carter,et al. A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. , 1981, The Journal of biological chemistry.
[42] J. Folch,et al. Isolation of brain strandin, a new type of large molecule tissue component. , 1951, The Journal of biological chemistry.
[43] J. Folch,et al. Proteolipides, a new type of tissue lipoproteins; their isolation from brain. , 1951, The Journal of biological chemistry.
[44] R. G. Anderson. The caveolae membrane system. , 1998, Annual review of biochemistry.
[45] D. Kingsley,et al. Analysis of the synthesis, intracellular sorting, and function of glycoproteins using a mammalian cell mutant with reversible glycosylation defects. , 1989, Methods in cell biology.